HEREDITARY ANGIOEDEMA - TYPE 3

Clinical trials for HEREDITARY ANGIOEDEMA - TYPE 3 explained in plain language.

Never miss a new study

Get alerted when new HEREDITARY ANGIOEDEMA - TYPE 3 trials appear

Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA - TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New pill aims to stop dangerous swelling attacks

Symptom relief ENROLLING_BY_INVITATION

This study is testing the long-term safety and effectiveness of an oral medication called deucrictibant for treating sudden swelling attacks in people with hereditary angioedema (HAE). It will enroll about 150 adults and adolescents who have HAE and have participated in related s…

Matched conditions: HEREDITARY ANGIOEDEMA - TYPE 3

Phase: PHASE2, PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief

Last updated Mar 20, 2026 14:48 UTC

HEREDITARY ANGIOEDEMA - TYPE 3

Get alerted when new HEREDITARY ANGIOEDEMA - TYPE 3 trials appear

New pill aims to stop dangerous swelling attacks